<div id="readability-page-1"><div><p><span>Nayak Sanjay Officer of Ocular Therapeutix Inc [OCUL] filed a Form 4 on November 26, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><td><span>Date</span></td><td><span>11/24/25</span></td></tr><tr><td><span>Transaction</span></td><td><span>Planned Surrender(1)(2)</span></td></tr><tr><td><span>Shares</span></td><td><span>1,878</span></td></tr><tr><td><span>Price</span></td><td><span>$12.04</span></td></tr><tr><td><span>Value</span></td><td><span>$22,611</span></td></tr></tbody></table></div><p><span>Ending Holdings: 277,860 - Direct</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

OCUL

<p>Nayak Sanjay, an officer of Ocular Therapeutix Inc, filed a Form 4 with the SEC on November 26, 2025, disclosing the surrender of 1,878 shares at $12.04 each, valued at $22,611. This transaction was executed under a prearranged trading plan (10b5-1) to cover option exercise costs and/or tax liabilities. The officer's ending holdings are 277,860 shares.</p>

Officer Nayak Surrenders 1,878 Of Ocular Therapeutix Inc [OCUL]